Diagnosis, treatment and burden in advanced ovarian cancer: a UK real-world survey of healthcare professionals and patients-Reference-Cited by-同舟云学术

Diagnosis, treatment and burden in advanced ovarian cancer: a UK real-world survey of healthcare professionals and patients

Published:2024-09-04 Issue: Volume: Page:1-17
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Tookman Laura¹,Green Clare²,Leonard Katy³,Clare Victoria⁴,Patel Nafisa⁵,Dunlop Farah³,McCormack Stephen³^ORCID,Ellis Hilary⁶^ORCID,Courcy Joanna de⁶^ORCID,Bateman Lauren⁶,Borley Jane⁷

Affiliation:

1. Imperial College Healthcare NHS Trust, London, United Kingdom

2. University Hospital Southampton NHS Foundation Trust, Southampton, UK

3. GlaxoSmithKline, Middlesex, UK

4. Ovacome, London, UK

5. Leicester Royal Infirmary Hospital, Leicester, UK

6. Adelphi Real World, Bollington, UK

7. Royal Cornwall Hospitals NHS Trust, Truro, UK

Funder

GlaxoSmithKline

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14796694.2024.2358742

Reference43 articles.

1. Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis

2. Measuring Quality of Life in Ovarian Cancer Clinical Trials—Can We Improve Objectivity and Cross Trial Comparisons?

3. Clinical epidemiology of epithelial ovarian cancer in the UK

4. Ovarian Cancer Audit Feasibility Pilot (OCAFP) [Internet]. UK: National Disease Registration Service (NDRS); 2025 [cited 2024 May 6]. Available from: https://digital.nhs.uk/ndrs/our-work/ncras-partnerships/ovarian-cancer-feasibility-pilot#outputs-and-publications

5. Ovarian Cancer Audit Feasibility Pilot [Internet]. UK: NHS England Digital; 2022 [cited 2024 May 6]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/ovarian-cancer-audit-feasibility-pilot